Short Summary
The PTAB denied Pharaoh Energy Services' petition to institute IPR proceedings against Flex-Chem for patent 9944843, citing a lack of compelling merits. The Board found that the cumulative weight of Fintiv factors and insufficient technical basis in the petitioner’s evidence led to the denial.
Detailed Summary
The Patent Trial and Appeal Board denied Pharaoh Energy Services' petition to institute IPR proceedings against Flex-Chem Holding Company and Flex-Chem Services Corporation regarding patent 9944843. Although the petitioner asserted grounds of anticipation (102) and obviousness (103) over prior art references Frenier and Reyes, the Board determined that the merits were not compelling enough to warrant institution under 35 U.S.C. § 314(a). The decision heavily relied on an analysis of the Fintiv factors, where the proximity of trial date and overlap with parallel district court litigation strongly favored denial. Furthermore, the Board found Petitioner's reliance on expert declarations was inadequate because they lacked technical depth regarding key limitations like 'nano-darcy shale formation.'
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Pharaoh Energy Services, LLC vs Flex-Chem Holding Company, LLC et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Nearmap US, Inc.vsPictometry International Corp. et al.
Nearmap US, Inc. challenged U.S. Patent 9,182,657 on grounds of obviousness (103) and anticipation (102). The petitioner argues that combinations of prior art references—including Loewen, Fujimoto, Mostafa, and Kain—render the claimed aerial image capture technology obvious. This is a challenger's opening petition for review in the field of Aerial Image Capture and Geolocation.
Curio Bioscience, Inc.vsPrognosys Biosciences Inc. et al.
Curio Bioscience petitions the PTAB to invalidate 13 claims of a spatial transcriptomics patent owned by Prognosys/10x Genomics, alleging obviousness over Cantor and Armani and anticipation by Frisen.
Intel Corporation et al.vsAdvanced Cluster Systems, Inc.
Intel and AMD have filed an IPR petition challenging all 30 claims of ACS’s ’621 patent covering parallel MATLAB execution on computer clusters, asserting obviousness over earlier Cornell publications and IBM documentation.
SAMSUNG ELECTRONICS CO., LTD. et al.vsOMNI MEDSCI, INC.
Samsung and co‑petitioners have filed an IPR petition seeking to invalidate 18 claims of Omni MedSci’s wearable health‑monitoring patent. They argue the claims are obvious over a combination of prior‑art references and that collateral estoppel bars re‑litigation.
Microsoft Corporation et al.vsDialect, LLC
Microsoft has filed an IPR petition challenging eight claims of Dialect’s 8,195,468 patent covering multimodal voice‑assistant technology, asserting obviousness over the Maes, Coffman, and Ittycheriah references. The petition argues the examiner never considered these references, creating a material error, and urges the Board to institute review.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.